| scholarly article | Q13442814 |
| P2093 | author name string | Gilles Courtois | |
| Laurent Parmentier | |||
| Francette Jean-Louis | |||
| Laurence Michel | |||
| Aurore Sors | |||
| Louis Dubertret | |||
| Elodie Bégué | |||
| Hervé Bachelez | |||
| Michel Dreano | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 901-911 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents | |
| P478 | volume | 14 |
| Q47902760 | A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas. |
| Q38890130 | Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target. |
| Q39979759 | Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells |
| Q42004035 | Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma |
| Q34802998 | Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL. |
| Q38909786 | Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells |
| Q37944565 | Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management |
| Q27024076 | Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management |
| Q36470196 | Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management |
| Q48034709 | Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. |
| Q37967108 | Cutaneous lymphomas: molecular pathways leading to new drugs |
| Q37237464 | Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma |
| Q47699242 | Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides |
| Q31028788 | Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines. |
| Q36020985 | Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma |
| Q36311738 | NF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia |
| Q38162229 | NFκB function and regulation in cutaneous T-cell lymphoma |
| Q39455873 | Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand |
| Q39187805 | Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma. |
| Q37929548 | Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome. |
| Q39778784 | Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP. |
| Q38505009 | Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868 |
| Q31022986 | Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies. |
| Q40476069 | T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy. |
| Q35071772 | c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death |
Search more.